INS and metabolic syndrome: Defects in insulin production and action cause hyperglycemia and other metabolic abnormalities associated with T2D through uncontrolled hepatic gluconeogenesis and dyslipidemia due to the dysregulation of fatty acid, triglyceride, and lipoprotein metabolism (Muoio and Newgard 2008).